These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27616561)

  • 1. Present and future of biologic drugs in primary Sjögren's syndrome.
    Sambataro D; Sambataro G; Dal Bosco Y; Polosa R
    Expert Opin Biol Ther; 2017 Jan; 17(1):63-75. PubMed ID: 27616561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and novel biologic drugs in primary Sjögren's syndrome.
    Fasano S; Isenberg DA
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):167-174. PubMed ID: 31025931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic treatments in Sjögren's syndrome.
    Bowman S; Barone F
    Presse Med; 2012 Sep; 41(9 Pt 2):e495-509. PubMed ID: 22836195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for primary Sjögren's syndrome.
    Gandolfo S; De Vita S
    Expert Opin Emerg Drugs; 2019 Jun; 24(2):121-132. PubMed ID: 31286787
    [No Abstract]   [Full Text] [Related]  

  • 5. New biological therapies in Sjögren's syndrome.
    Nocturne G; Cornec D; Seror R; Mariette X
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):783-93. PubMed ID: 27107513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies in primary Sjögren's syndrome.
    Ng WF; Bowman SJ
    Expert Opin Biol Ther; 2011 Jul; 11(7):921-36. PubMed ID: 21457124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapies in primary Sjögren's syndrome.
    Bowman SJ
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1997-2008. PubMed ID: 22208654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
    Brito-Zerón P; Ramos-Casals M;
    Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future treatments for Sjögren's syndrome.
    Pers JO; Saraux A
    Presse Med; 2016 Jun; 45(6 Pt 2):e193-200. PubMed ID: 27242213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of biologic agents in the treatment of Sjögren's syndrome.
    Meijer JM; Pijpe J; Bootsma H; Vissink A; Kallenberg CG
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):292-7. PubMed ID: 17992596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in primary Sjögren's syndrome: a ten-year journey.
    Carubbi F; Alunno A; Cipriani P; Bartoloni E; Ciccia F; Triolo G; Gerli R; Giacomelli R
    Lupus; 2014 Nov; 23(13):1337-49. PubMed ID: 25096066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.
    Both T; Dalm VA; van Hagen PM; van Daele PL
    Int J Med Sci; 2017; 14(3):191-200. PubMed ID: 28367079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic treatment in Sjögren's syndrome.
    Sada PR; Isenberg D; Ciurtin C
    Rheumatology (Oxford); 2015 Feb; 54(2):219-30. PubMed ID: 25342375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Sjögren's syndrome: current therapy and future directions.
    Fox RI; Fox CM; Gottenberg JE; Dörner T
    Rheumatology (Oxford); 2021 May; 60(5):2066-2074. PubMed ID: 31034046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year in review 2015: Sjögren's syndrome.
    Luciano N; Valentini V; Calabrò A; Elefante E; Vitale A; Baldini C; Bartoloni E
    Clin Exp Rheumatol; 2015; 33(2):259-71. PubMed ID: 25896475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain.
    Carsons SE; Vivino FB; Parke A; Carteron N; Sankar V; Brasington R; Brennan MT; Ehlers W; Fox R; Scofield H; Hammitt KM; Birnbaum J; Kassan S; Mandel S
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):517-527. PubMed ID: 27390247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year in review 2017: primary Sjögren's syndrome.
    Ferro F; Marcucci E; Orlandi M; Baldini C; Bartoloni-Bocci E
    Clin Exp Rheumatol; 2017; 35(2):179-191. PubMed ID: 28337967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited efficacy of targeted treatments in Sjögren's syndrome: why?
    Tzioufas AG; Goules AV
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):27-28. PubMed ID: 29998826
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Biologics in Sjögren's Syndrome.
    Nocturne G; Cornec D; Seror R; Mariette X
    Rheum Dis Clin North Am; 2016 Aug; 42(3):407-17. PubMed ID: 27431344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in Sjogren's syndrome.
    Thalayasingam N; Baldwin K; Judd C; Ng WF
    Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi53-vi61. PubMed ID: 34951923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.